NCIt definition : An orally bioavailable inhibitor of the alpha and beta isoforms of p38 mitogen-activated
protein kinase (MAPK), with potential immunomodulating and anti-inflammatory activities.
Upon oral administration, losmapimod inhibits the activity of p38alpha/beta MAPK,
thereby preventing p38alpha/beta MAPK-mediated signaling. This may result in the inhibition
of the production of proinflammatory cytokines. p38 MAPK, a serine/threonine protein
kinase, plays an important role in regulating the transcription and translation of
cytokines involved in inflammation including tumor necrosis factor alpha (TNF-alpha)
and interleukin (IL)-1, IL-6 and IL-8.;
UNII : F2DQF16BXE;
InChIKey : KKYABQBFGDZVNQ-UHFFFAOYSA-N;
CAS number : 585543-15-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 585543-15-3
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;